Skip to content

Author

M. Cruellas

We have 2 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

CDH1 germline carriers and diffuse gastric Cancer: Are we ready for personalized surveillance and prevention?

Hereditary diffuse gastric cancer (HDGC) caused by germline pathogenic or likely pathogenic variants in CDH1 remains a difficult hereditary cancer syndrome to manage. Prophylactic total gastrectomy has long been considered the most definitive preventive strategy, but recent penetrance estimates, expert endoscopic surve...

M. Cruellas, J. Castillo-Iturra, Tian V. Tian et al. · 0 citations
Open access Jul 2026

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer

BRCA2 PVs were independently associated with poorer outcomes to first-line CDK4/6i plus ET in HR-positive/HER2-negative MBC compared with controls, especially relevant among patients with endocrine-sensitive disease.

M. Cruellas, A. Rodriguez-Hernandez, L. Carità et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.